Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Stutz

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature|December 21, 2012
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 miceMichael T Heneka, Markus P Kummer, Andrea Stutz, et al.
Nature Immunology|June 23, 2014
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammationBernardo S Franklin, Lukas Bossaller, Dominic De Nardo, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
Journal of Medicinal Chemistry|March 4, 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.
The Journal of Allergy and Clinical Immunology|February 21, 2017
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinaseXiao Liu, Tica Pichulik, Olaf-Oliver Wolz, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature|December 21, 2012
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 miceMichael T Heneka, Markus P Kummer, Andrea Stutz, et al.
Nature Immunology|June 23, 2014
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammationBernardo S Franklin, Lukas Bossaller, Dominic De Nardo, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
Journal of Medicinal Chemistry|March 4, 2025
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome InhibitorDong-Ming Shen, Kate F Byth, Damien Bertheloot, et al.
The Journal of Allergy and Clinical Immunology|February 21, 2017
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinaseXiao Liu, Tica Pichulik, Olaf-Oliver Wolz, et al.
Pageof 2